BRIEF-Cardiome and Allergan announce Xydalba(tm) licensing agreement in international markets
May 5 (Reuters) - Cardiome Pharma Corp
* Additional terms of agreement were not disclosed.
* Cardiome and allergan announce xydalba(tm) (dalbavancin) licensing agreement in international markets
* Expects to initiate commercial sales of xydalba in its territories as early as 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.